Browsing: FDA

Hims’ Super Bowl ad has drawn criticism for its provocative claims about the weight loss industry and pharmaceutical companies.

A new study reveals manufacturers often submit medical device adverse event reports late. Also, senators are questioning telehealth platforms’ ties to pharmaceutical companies, and Hinge Health plans its IPO.

A recap of significant developments in health technology, including late FDA reports on adverse events, senators questioning telehealth-pharma ties, a look at Hinge Health’s IPO plans, and Apple’s Parkinson’s tech.

Johnson & Johnson MedTech announced new regulatory clearances for its orthopedic technologies, including the VOLT system and Inhance Intact system.

AdvaMed presents its priorities for fostering medical innovation, improving patient access, and strengthening the U.S. medtech industry’s global leadership.

A federal judge in Texas has rejected a request to allow compounding pharmacies to produce a popular weight loss medication, upholding the FDA’s authority on drug manufacturing.

An analysis of the evolving regulatory landscape surrounding AI and machine learning in healthcare, focusing on developments in the U.S., European Union, and China.

The Food and Drug Administration (FDA) has released new draft guidance for developers of medical devices that use artificial intelligence.

An analysis of potential repercussions stemming from reported staffing changes at the FDA, and the role of AI experts.

HeartBeam, a health technology company, is raising funds to support its FDA-cleared 12-lead ECG device.